QP24-25 Commercial Pharmacy Benefit Exclusion for Octreotide Kit, Sandostatin® Kit LAR, and Signifor® LAR injection

QP23-25 Commercial Pharmacy Benefit Exclusion for Kebilidi™, Niktimvo™, Steqeyma® and Yesintek™

QP22-25 Provider Press: Q1 2025

QP21-25 Appropriate Use of Modifier -25

MHCP Pharmacy Program Policy Activity Effective May 1, 2025

MHCP Pharmacy Program Policy Activity Effective April 1, 2025

QP30-25 Accurate Place of Service on Claim Submission

2q-2025-utilization-management-updates.pdf

2023 Prior Authorization approvals and appeals statistics — Blue Cross Plans

Prior Authorizations for Services Provided from January 1, 2023 to December 31, 2023 — Blue Cross Plans

2023 Prior Authorization approvals and appeals statistics — Blue Plus Plans

Prior Authorizations for Services Provided from January 1, 2023 to December 31, 2023 — Blue Plus Plans